Performant to Participate in the Upcoming Oppenheimer Emerging Growth Conference

PLANTATION, Fla.--(BUSINESS WIRE)-- Performant Healthcare, Inc. (Nasdaq: PHLT) (“Performant”), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that it will participate in the 10th Annual Oppenheimer Emerging Growth Conference on Wednesday, February 26th.

Performant’s Chief Financial Officer, Rohit Ramchandani, will participate in one-on-one meetings to discuss key topics, including the potential company’s impact under the new administration and developments in DOGE. These meetings will be held virtually on February 26th.

To schedule a meeting, please contact Performant or your Oppenheimer representative.

ABOUT PERFORMANT

Performant supports healthcare payers in identifying, preventing, and recovering waste and improper payments by leveraging advanced technology, analytics and proprietary data assets. Performant works with leading national and regional healthcare payers to provide eligibility-based, also known as coordination-of-benefits (COB) services, as well as claims-based services, which includes the audit and identification of improperly paid claims. Performant is a leading provider of these services in both government and commercial healthcare markets. Performant also provides advanced reporting capabilities, support services, customer care, and stakeholder training programs designed to mitigate future instances of improper payments.

To learn more about Performant, please visit https://www.performanthealthcare.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250219500623/en/

Jon Bozzuto
Investor Relations
925-960-4988
[email protected]

Source: Performant Healthcare, Inc.

You May Also Be Interested In

• Statement of B&G Foods Regarding the Competition Bureau Challenge of Pending Sale of Green Giant Canada to Nortera
• AI Memecoin Agents To Buy 2026: MemeToro Gains Attention As Institutional Capital Rotates Into AI Crypto
• Ingenia Therapeutics Nominated for Both the Prix Galien USA and the Inaugural Prix Galien Korea for Best Startup